510(k) K262893

Eonis™ SMA kit by Revvity, Inc. — Product Code QUE

K262893 is an FDA 510(k) premarket notification submitted by Revvity, Inc. for the device "Eonis™ SMA kit". The FDA issued a decision of Substantially Equivalent on Sep 30, 2026. The device falls under product code QUE (Spinal Muscular Atrophy Newborn Screening Test System), a Class II device regulated under 21 CFR 866.5980.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Sep 30, 2026
Date Received
Aug 17, 2026
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Spinal Muscular Atrophy Newborn Screening Test System
Device Class
Class II
Regulation Number
866.5980
Review Panel
MG
Submission Type
510(k)

A Spinal Muscular Atrophy (SMA) newborn screening test system is a prescription device intended to detect homozygous deletion of exon 7 or other similar mutations in the SMN1 (Survival Motor Neuron 1) gene of DNA obtained from dried blood spot specimens on filter paper using a polymerase chain reaction-based test as an aid in screening newborns for SMA. Presumptive positive results are intended to be followed up by diagnostic confirmatory testing.

Need the full FDA record for Revvity, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K262893. Report a data issue: hello@regdatalab.com.